In patients receiving bone marrow transplant for Fanconi anemia, overall survival is nearly 20% higher for those treated since 2008, shows a recent study.Read More
Haploidentical bone marrow transplantation may help increase the donor pool for patients with sickle cell disease. A recent study reports two-year event-free survival comparable to matched sibling donor myeloablative transplant.
Cleveland Clinic hematologist Faiz Anwer, MD, explains the gene editing technology CRISPR.
Results from two early-phase trials suggest that CRISPR/CASP 12 gene editing has the potential to cure sickle cell disease and transfusion-dependent beta-thalassemia.
A leader of our Gamma Knife Center shares how this stereotactic radiosurgery technology has progressed over recent decades and where it may be headed next.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Global study examines disparities in medication toxicity for patients with multiple myeloma.
Clinical trial offers treatment for older patients with large B-cell lymphoma.
Virtual Anemia Clinic supports patients with assessment, diagnosis and treatment for iron deficiency, nutritional anemia and related conditions.
Breast cancer vaccine trials take next steps forward.
Patients and their care partners have access to a wide range of support services to help address the mental and physical toll of cancer treatment.
Cleveland Clinic specialists bring a wide array of fertility-preservation options to patients facing cancer and other conditions.